ecteinascidin 743 has been researched along with Metastase in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (20.00) | 29.6817 |
2010's | 16 (64.00) | 24.3611 |
2020's | 4 (16.00) | 2.80 |
Authors | Studies |
---|---|
Itonaga, I; Iwasaki, T; Kawano, M; Matsuda, S; Tanaka, K; Tsumura, H | 1 |
Alastuey, I; Alvarez, R; Alvarez-Gonzalez, A; Belinchon, B; Blay, JY; Coindre, JM; Cruz-Jurado, J; Dei Tos, AP; Dolado, MC; Gatti, M; Grignani, G; Gronchi, A; Gutierrez, A; Hindi, N; Isern-Verdum, J; Italiano, A; Lopez-Pousa, A; Luna, P; Martin-Broto, J; Martinez-Serra, J; Morosi, C; Moura, DS; Peinado-Serrano, J; Redondo, A; Rincon-Pérez, I; Romagosa, C; Romero, J; Sanchez-Bustos, P; Sargos, P; Sunyach, MP | 1 |
Asanuma, K; Hagi, T; Nakamura, T; Sudo, A | 1 |
Chiba, K; Horiuchi, K; Inoue, M; Ishizaka, T; Matsuhashi, Y; Rikitake, H; Susa, M; Taguchi, E | 1 |
Sleijfer, S; Vos, M | 1 |
Belotti, D; Borsotti, P; Carminati, L; D'Incalci, M; Giavazzi, R; Minoli, L; Pinessi, D; Taraboletti, G | 1 |
Cornillie, J; Debiec-Rychter, M; Hompes, D; Langmans, C; Schöffski, P; Sciot, R; van Cann, T; Vandenbempt, I; Wozniak, A | 1 |
Papaioannou, D; Rafia, R; Simpson, E; Stevenson, M | 1 |
Ahrens, M; Bauer, S; Grabellus, F; Hoiczyk, M; Podleska, L; Pöttgen, C; Schuler, M; Schwindenhammer, B; Taeger, G | 1 |
Alam, S; Davidson, D; Earl, HM; Gounaris, I; Hatcher, HM; Horan, G; Sherbourne, K; Zaki, KA | 1 |
Alexandre, J; Bertucci, F; Bompas, E; Chevreau, C; Collard, O; Cupissol, D; Delcambre, C; Duffaud, F; Floquet, A; Guillemet, C; Isambert, N; Lacas, B; Lavau-Denes, S; Le Cesne, A; Pautier, P; Penel, N; Piperno-Neumann, S; Selle, F; Soulié, P; Thyss, A; Toulmonde, M | 1 |
Blay, JY; Bui-Nguyen, B; Butrynski, JE; Collin, F; Isambert, N; Kerst, JM; Litière, S; Marréaud, S; Milhem, M; Penel, N; Reyners, AK; van der Graaf, WT | 1 |
D'Incalci, M; Zambelli, A | 1 |
Balzarini, L; Bastoni, S; Bertuzzi, AF; Daolio, P; De Sanctis, R; Lutman, FR; Marchetti, S; Marrari, A; Mussi, C; Quagliuolo, V; Santoro, A | 1 |
Allavena, P; Belli, C; Cangi, MG; Cappio, S; Ceraulo, D; D'Incalci, M; Doglioni, C; Dugnani, E; Garassini, G; Maggiora, P; Piemonti, L; Porcu, L; Reni, M; Zucchetti, M | 1 |
Amunni, G; Lavacchi, D; Mazzei, T; Montelatici, S; Tavella, K; Vannini, L; Villanucci, A | 1 |
Dumez, H; Jimeno, J; Schöffski, P; Stefan, C; Van Oosterom, AT; Wolter, P; Wozniak, A | 1 |
Adenis, A; Hollebecque, A; Lebedinsky, C; Penel, N; Taieb, S | 1 |
Dimitrakopoulou-Strauss, A; Egerer, G; Ho, AD; Kasper, B; Schmitt, T; Wuchter, P | 1 |
García San Andrés, B; Joensuu, T; Soini, EJO | 1 |
Blomqvist, C; Johansson, R; Tarkkanen, M | 1 |
Bellmunt, J; Cullell-Young, M; Goel, S; Hudes, GR; Kahatt, C; Kantoff, PW; Lardelli, P; Lee, RJ; Lewis, NL; Michaelson, MD; Nieto, A; Pardos, I; Smith, MR; Stein, CA | 1 |
Canniff, J; Demetri, GD; Garcia-Carbonero, R; Gomez, J; Goss, G; Guzman, C; Harmon, D; Jimeno, J; Lopez, T; Maki, RG; Manola, J; Matulonis, U; Merriam, P; Puchalski, TA; Quigley, MT; Ryan, DP; Sancho, MA; Seiden, MV; Supko, JG | 1 |
Alberti, L; Blay, JY; Boyle, H; Coquard, IR; Decouvelaere, AV; Fayette, J; Méeus, P; Ranchère, D; Sunyach, MP; Thiesse, P | 1 |
Dean-Colomb, W; Esteva, FJ | 1 |
6 review(s) available for ecteinascidin 743 and Metastase
Article | Year |
---|---|
EJC's biennial report on metastatic soft tissue sarcoma: State of the art and future perspectives.
Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Drug Therapy; Forecasting; Humans; Indazoles; Neoplasm Metastasis; Pyrimidines; Sarcoma; Sulfonamides; Tetrahydroisoquinolines; Trabectedin | 2018 |
Trabectedin for the treatment of advanced metastatic soft tissue sarcoma: a NICE single technology appraisal.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Support Techniques; Dioxoles; Disease-Free Survival; Humans; Models, Theoretical; Neoplasm Metastasis; Quality-Adjusted Life Years; Sarcoma; Survival Rate; Tetrahydroisoquinolines; Trabectedin; United Kingdom | 2013 |
Trabectedin for the treatment of breast cancer.
Topics: Animals; Antineoplastic Agents, Alkylating; Breast Neoplasms; Dioxoles; DNA Repair; Female; Humans; Neoplasm Metastasis; Tetrahydroisoquinolines; Trabectedin; Tumor Microenvironment | 2016 |
Clinical impact of trabectedin (ecteinascidin-743) in advanced/metastatic soft tissue sarcoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Dioxoles; Disease-Free Survival; Humans; Molecular Structure; Neoplasm Invasiveness; Neoplasm Metastasis; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2008 |
ET-743: a novel agent with activity in soft-tissue sarcomas.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Dioxoles; Disease-Free Survival; DNA; DNA Repair; Humans; Models, Chemical; Neoplasm Metastasis; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2006 |
Emerging agents in the treatment of anthracycline- and taxane-refractory metastatic breast cancer.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Clinical Trials as Topic; Deoxycytidine; Dioxoles; Diphtheria Toxin; Drug Resistance, Neoplasm; Drugs, Investigational; Epothilones; Female; Furans; Gemcitabine; Glutamates; Guanine; Humans; Interleukin-2; Ketones; Lapatinib; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pemetrexed; Quinazolines; Recombinant Fusion Proteins; Tetrahydroisoquinolines; Trabectedin; Vinblastine; Vinorelbine | 2008 |
6 trial(s) available for ecteinascidin 743 and Metastase
Article | Year |
---|---|
Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas: A Nonrandomized Phase 1/2 Clinical Trial.
Topics: Adult; Aged; Combined Modality Therapy; Disease-Free Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; France; Humans; Italy; Male; Middle Aged; Neoplasm Metastasis; Sarcoma; Spain; Trabectedin | 2020 |
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dioxoles; Doxorubicin; Female; Humans; Kaplan-Meier Estimate; Leiomyosarcoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Trabectedin; Uterine Neoplasms | 2015 |
A phase IIb multicentre study comparing the efficacy of trabectedin to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma: the TRUSTS trial.
Topics: Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Dioxoles; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2015 |
Phase II trial of salvage therapy with trabectedin in metastatic pancreatic adenocarcinoma.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents, Alkylating; Deoxycytidine; Dioxoles; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Pancreatic Neoplasms; Prognosis; Prospective Studies; Salvage Therapy; Survival Rate; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2016 |
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Cohort Studies; Dioxoles; Humans; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Prostatic Neoplasms; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Treatment Failure; Treatment Outcome | 2012 |
Phase II and pharmacokinetic study of ecteinascidin 743 in patients with progressive sarcomas of soft tissues refractory to chemotherapy.
Topics: Adult; Antineoplastic Agents, Alkylating; Dioxoles; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Humans; Isoquinolines; Male; Middle Aged; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms; Survival Rate; Tetrahydroisoquinolines; Trabectedin | 2004 |
13 other study(ies) available for ecteinascidin 743 and Metastase
Article | Year |
---|---|
Long-term disease control by trabectedin in a patient with dedifferentiated liposarcoma: A case report.
Topics: Aged; Antineoplastic Agents, Alkylating; Humans; Liposarcoma; Male; Neoplasm Metastasis; Trabectedin | 2020 |
Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Female; Furans; Humans; Indazoles; Japan; Kaplan-Meier Estimate; Ketones; Male; Middle Aged; Neoplasm Metastasis; Prognosis; Pyrimidines; Retrospective Studies; Sarcoma; Soft Tissue Neoplasms; Sulfonamides; Survival Analysis; Trabectedin; Treatment Outcome | 2020 |
Trabectedin suppresses osteosarcoma pulmonary metastasis in a mouse tumor xenograft model.
Topics: Adolescent; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Heterografts; Humans; Lung Neoplasms; Mice; Neoplasm Metastasis; Osteosarcoma; Trabectedin | 2022 |
Antimetastatic and antiangiogenic activity of trabectedin in cutaneous melanoma.
Topics: Angiogenesis Inhibitors; Animals; Cell Line; Cell Line, Tumor; Female; Macrophages; Melanoma; Melanoma, Cutaneous Malignant; Melanoma, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Neoplasm Metastasis; NIH 3T3 Cells; Skin Neoplasms; Tissue Inhibitor of Metalloproteinase-1; Trabectedin; Tumor Microenvironment | 2019 |
Retrospective Analysis of Patients with Advanced Liposarcoma in a Tertiary Referral Center.
Topics: Adult; Aged; Antineoplastic Agents; Disease Progression; Doxorubicin; Female; Humans; Ifosfamide; Liposarcoma; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Survival Analysis; Tertiary Care Centers; Trabectedin; Treatment Outcome; Young Adult | 2019 |
Trabectedin in metastatic soft tissue sarcomas: Role of pretreatment and age.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Dioxoles; Disease Progression; Disease-Free Survival; Female; Humans; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2013 |
Trabectedin for advanced soft tissue sarcomas: a single institution experience.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Female; Humans; Male; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Sarcoma; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Young Adult | 2014 |
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leiomyosarcoma; Liposarcoma; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Sarcoma; Survival Rate; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Young Adult | 2015 |
Stable disease in a patient with metastatic leiomyosarcoma treated with trabectedin.
Topics: Aged; Antineoplastic Agents, Alkylating; Dioxoles; Female; Humans; Leiomyosarcoma; Neoplasm Metastasis; Tetrahydroisoquinolines; Trabectedin; Uterine Neoplasms | 2017 |
Inadequacy of size-based response criteria to assess the efficacy of trabectedin among metastatic sarcoma patients.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials, Phase II as Topic; Dioxoles; Humans; Leiomyosarcoma; Male; Middle Aged; Neoplasm Metastasis; Peritoneal Neoplasms; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome | 2010 |
The use of positron emission tomography in soft tissue sarcoma patients under therapy with trabectedin.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Pilot Projects; Positron-Emission Tomography; Sarcoma; Soft Tissue Neoplasms; Tetrahydroisoquinolines; Tomography, X-Ray Computed; Trabectedin; Treatment Outcome | 2009 |
Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information.
Topics: Antineoplastic Agents, Alkylating; Cost-Benefit Analysis; Dioxoles; Humans; Markov Chains; Models, Statistical; Neoplasm Metastasis; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2011 |
Trabectedin in the treatment of metastatic soft-tissue sarcoma: cost-effectiveness and cost-utility are yet to be proved.
Topics: Antineoplastic Agents, Alkylating; Cost-Benefit Analysis; Dioxoles; Humans; Neoplasm Metastasis; Sarcoma; Tetrahydroisoquinolines; Trabectedin | 2011 |